ACPU Relaunch is a Go!

Published 6th June, 2020

We are excited to announce the Relaunch of the Association of Clinical Pharmacology Units (ACPU) and want to share next steps in hopes you will join in this important mission.

Now more than ever ACPU is needed as an organization representing this changing world of early phase clinical trials. ACPU’s members represent CROs, academic CPUs, consultants, vendors, biopharma companies and ancillary services of all sorts that have a stake in how early clinical trials are conducted.

Our basic mission remains as it has since 1990: To provide a forum facilitating cooperation and the exchange of information and ideas among professionals involved in the conduct of early phase clinical research. Our primary approach is to support those in the field through:

  • Networking to discuss our professional roles, best practices, and the ever changing environment in which we operate.
  • Promoting standards of practice and guidelines for the conduct of early phase clinical research.
  • Educating our membership and those who depend on us.

Relaunch Steps Underway:

  • Phase I Industry Survey - completed Fall 2019
  • Relaunch Meeting via WebEx – completed March 2020
  • ACPU & Corporate Membership Extension – All active & corporate members from 2015 are granted membership privileges through 2020
    • Corporate Members:
      • AbbVie Clinical Trials of Texas
      • Compass Research
      • Clinical Trials of Texas
      • Covance
      • New Orleans Center for Clinical Research
      • Orlando Center for Clinical Research (OCCR)
      • PRA Health Sciences
      • Quintiles
      • Worldwide Clinical Trials
  • Board Election – Election for Board of Directors planned for late June 2020
    • Slate of Nominees
      • President
      • President-Elect,
      • Immediate Past President
      • Secretary
      • Treasurer
      • 6 Trustee positions
    • Email will be sent to all current ACPU contacts asking for Board of Director nominations
    • Election will be via WebEx meeting

 

 

A letter from ACPU President, Angela Baker

Thank you to everyone who made our 23rd ACPU Annual Meeting in Denver one of the most successful in the organization’s history!

Special appreciation goes to this year’s host and platinum sponsor, DaVita Clinical Research (link to Davita website when clicking on name) & our Program Committee chaired by Harry Alcorn and Donna Dorozinsky along with, Steve Satek and Kris Marshall.

More than 25 different companies with Phase I units including academic units, pharma owned units, commercial clinics and early phase research networks along with more than 15 partner companies (IRBs, technology providers, and others) came together last month at the annual meeting.   ACPU continues to be the voice for early phase clinical research conduct, and with more than 2,750 beds at CPUs across the United States and Canada represented in Denver, that voice is stronger than ever.

This year’s meeting theme, Leveraging Partnerships & Collaboration to Address Complexity in Today’s Early-Phase Clinical Trials continues to resonate as the early phase research community rallies to contribute to medical advances amidst the coverage of a rising Ebola epidemic, mental health crises and growing outcry for better treatment options for Alzheimer’s, Cancer and other diseases.

Collaboration is be defined as “coming together to work toward a common vision” which is really at the heart of ACPU.    While individually we each work tirelessly to move our respective organizations forward, ACPU is about moving the early clinical research industry forward – Building a Better Phase I Community

Presentations are posted on the ACPU website for access by members and meeting registrants. And, plans are already underway to make 2015 an even better Annual Meeting.  If you are interested in sponsoring next year’s meeting, serving on the programming committee or suggesting a speaker or topic, please contact me or one of our board members.  In the words of former ACPU President Howard Greenburg, “Remember, it is YOUR ACPU.”

In this season of Thanksgiving, we would be remiss without also recognizing our Board Members who give unselfishly of their time and talent to move this organization forward.  Please join me in showing your appreciation for all that they do for ACPU.

We’d also like to acknowledge the support of our inaugural corporate members – AbbVie, Clinical Trials of Texas, Compass Research, Covance, New Orleans Center for Clinical Research, Orlando Center for Clinical Research, PRA Health Sciences, Quintiles, Worldwide Clinical Trials, and Vince & Associates Clinical Research!

And, while we’ve accomplished so many significant milestones this past year, we also look to 2015 and realize there is still much work to be done.  It’s an exhilarating and worthwhile journey, and I am confident that in working together we can get the job done.

In the meantime, wishing everyone a wonderful holiday season full of many blessings!

With Appreciation,

Angela